Novo Nordisk A/S: all 1,444 studies

Page 6 of 15. Open to participants first (108), then studies with results posted, then the rest; newest registration first within each.

• A Study to Understand the Real-world Awareness and Perceptions of Systemic inFLAMmation and rolE of hsCRP as a Biomarker in Patients With AtheroSclerotic CardioVascular Disease and Chronic Kidney Disease Among NephrologistsCompletedNCT06322641
• A Study to Test How Either a Capsule or a Tablet With NDec (Decitabine and Tetrahydrouridine) Works in the Body of Healthy PeopleCompletedNCT06291285Phase 1
• A Study on How CagriSema Affects Levels of Atorvastatin and Warfarin in the Blood of Participants With Excess Body WeightCompletedNCT06289504Phase 1
• A Study to Test How a New Long-acting Insulin Works in the Body of Patients With Type 2 Diabetes During Exercise and Prolonged FastingCompletedNCT06288412Phase 1
• Prevalence and Economic Burden of Obesity-related Comorbidities in the Gulf Region: A Retrospective, Observational StudyCompletedNCT06288399
• A Research Study of a New Medicine (NNC0650-0013) in Healthy MenCompletedNCT06284798Phase 1
• Special Use - Results Surveillance on Long-term Use With Wegovy®Active, not recruitingNCT06283667
• Study to Evaluate the Safety and Effectiveness of Saxenda® for Weight Management in Routine Clinical Practice in Taiwan.CompletedNCT06283641
• SEMA-CardioDiab HUNGARY: A Research Study to Understand the Effects of Oral Semaglutide on Blood Sugar Levels, Weight, and Cardiovascular Risk in People With Type 2 Diabetes Patients in HungaryCompletedNCT06269120
• A Research Study to See How Well New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Levels in People With Type 2 Diabetes (T2D), Compared to Daily Insulin Glargine (COMBINE 4)CompletedNCT06269107Phase 3
• A Study of How CagriSema Works on Appetite in People With Excess Body WeightCompletedNCT06267092Phase 1
• A Research Study to Look at Long-term Treatment With a Medicine Called NNC6019-0001 for People Who Have Heart Failure Due to Transthyretin AmyloidosisActive, not recruitingNCT06260709Phase 2
• Assessing Health-Related Quality of Life and Willingness to Pay for Weight Management in Asia-Pacific by GenderCompletedNCT06260696
• A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Tirzepatide in People With Type 2 Diabetes Treated With Metformin With or Without an SGLT2 InhibitorCompletedNCT06221969Phase 3
• A Research Study to Look at How CagriSema Influences Food Intake, Appetite and Emptying of the Stomach in People With Excess Body WeightCompletedNCT06207877Phase 1
• A Research Study Looking Into How Ziltivekimab Works Compared to Placebo in Participants With Heart Failure and InflammationActive, not recruitingNCT06200207Phase 3
• A Research Study Looking at How the Compound NNC0194-0499 Works With Birth Control Pills in Women Not Able to Bear Children.CompletedNCT06188026Phase 1
• A Study Evaluating Efruxifermin in Subjects With Non-invasively Diagnosed Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Nonalcoholic Fatty Liver Disease (NAFLD)/Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)Active, not recruitingNCT06161571Phase 3
• A Research Study in Saudi Arabia to Understand How the Dose Check App Used With Tresiba Treatment Helps to Control Blood Sugar LevelCompletedNCT06153537
• A First Human Dose Study Investigating Safety and Concentration of Study Medicine in the Blood Following Once Daily Oral Dosing of NNC0560-0004 in Healthy Adults.CompletedNCT06133270Phase 1
• A Research Study to See How Well CagriSema Compared to Tirzepatide Helps People With Obesity Lose WeightCompletedNCT06131437Phase 3
• A Research Study to See if Kidney Damage in People With Chronic Kidney Disease and Type 2 Diabetes Living With Overweight or Obesity Can be Reduced by CagriSema Compared to Semaglutide, Cagrilintide and PlaceboCompletedNCT06131372Phase 2
• Levels of Inflammation in People With Cardiovascular Disease (POSEIDON)CompletedNCT06122961
• ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart AttackActive, not recruitingNCT06118281Phase 3
• A Research Study in Italy to Understand How the Dose Check App Used With Xultophy® Works in the Treatment of People Living With Type 2 DiabetesWithdrawnNCT06113341
• A Study of DCR-STAT3 in Adults With Solid TumorsCompletedNCT06098651Phase 1
• A Research Study Looking at New Protein-based Tablets in Healthy Men - Oral Formulation IIICompletedNCT06097390Phase 1
• Research Study to Compare Semaglutide Tablets With Empagliflozin or Metformin Tablets in People With Type 2 DiabetesWithdrawnNCT06083675Phase 3
• Investigation of Safety, Tolerability and Pharmacokinetics of Multiple Doses of NNC0113-6856 in Healthy Participants, Including a Subset of Healthy Japanese ParticipantsCompletedNCT06069895Phase 1
• A Research Study to See How Well CagriSema Compared to Semaglutide, Cagrilintide and Placebo Lowers Blood Sugar and Body Weight in People With Type 2 Diabetes Treated With Metformin With or Without an SGLT2 InhibitorCompletedNCT06065540Phase 3
• A Research Study to See How a New Medicine (NNC0487-0111) Works in People With Overweight or Obesity When Injected Under the SkinCompletedNCT06064006Phase 2
• A Research Study of How a New Medicine Called Amycretin, Given as Tablets, Works in Japanese Men With ObesityCompletedNCT06049329Phase 1
• A Research Study Comparing the Effect of Different Dosing Conditions on Blood Levels of Semaglutide in a New Tablet Composition in Healthy ParticipantsCompletedNCT05996874Phase 1
• A Research Study to See How Well CagriSema Helps People in China With Excess Body Weight Lose WeightCompletedNCT05996848Phase 3
• Treatment of Primary Hyperoxaluria Type 1 With NedosiranNo longer availableNCT05993416
• A Study to Look at How Safe a New Medicine (NNC0491-6075) is in Healthy People and in Participants With High Levels of Fat in the BloodCompletedNCT05979428Phase 1
• Reverse Remodeling Effects of CDR132L in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction and Cardiac HypertrophyWithdrawnNCT05953831Phase 2
• A Research Study Looking at How a Single Dose of the Study Medicine NNC0194-0499 Behaves in Participants With Reduced Liver Function Compared to Participants With Normal Liver FunctionCompletedNCT05917938Phase 1
• A Study of the Genetic Basis of Response to Growth Hormone Treatment in Children With Idiopathic Short StatureTerminatedNCT05894876
• Study of INV-202 in Patients With Obesity and Metabolic SyndromeCompletedNCT05891834Phase 2
• Research Study Looking at How Well Semaglutide Tablets Taken Once Daily Work in Chinese Adults Who Are Above a Healthy Weight Range (OASIS 3)CompletedNCT05890976Phase 3
• A Research Study Looking at How Safe it is to Switch From Emicizumab to Mim8 in People With Haemophilia A (FRONTIER 5)CompletedNCT05878938Phase 3
• A Study to Characterize the Prevalence of Overweight and Obesity Among Patients With Established Cardiovascular DiseaseCompletedNCT05873660
• A Research Study of a New Medicine NNC0519-0130 in Japanese and Non-Japanese MenCompletedNCT05870670Phase 1
• A Research Study to See How Well CagriSema Helps People in East Asia With Excess Body Weight Lose WeightCompletedNCT05813925Phase 3
• A Research Study Looking at How Cagrilintide Works on the Heart Rhythm in Healthy ParticipantsCompletedNCT05804162Phase 1
• A Study to Understand the Distribution of Obesity Classes and Obesity Related Diseases in People With Obesity Across Countries in Czech Republic, Hungary and PolandCompletedNCT05795166
• A Study to Test How New Long-acting Insulin (Insulin Icodec) Works in the Body of Children and TeenagersCompletedNCT05790681Phase 1
• A Research Study to Compare How Much Semaglutide is Found in the Blood With Different Tablets of Oral Semaglutide in Healthy ParticipantsCompletedNCT05784402Phase 1
• A Research Study Comparing Blood Levels of Medicines NNC0194-0499 and Semaglutide Administered as a Combination Formulation Versus Two Separate FormulationsCompletedNCT05766709Phase 1
• Barriers to MASLD Management in Europe: Findings From a Multidisciplinary HCP-surveyCompletedNCT05765890
• A Multinational Survey-based Study to Understand the Real-world Awareness and Perceptions of Systemic inFLAMmation and rolE of hsCRP as a Biomarker in Patients With AtheroSclerotic CardioVascular Disease and Chronic Kidney Disease Among CardiologistsCompletedNCT05755373
• DOORS: A Research Study to Understand How Oral Semaglutide Works in People With Type 2 Diabetes Who Change From Dipeptidyl Peptidase-4 Inhibitor (DPP4i) Treatment to Oral Semaglutide in ItalyCompletedNCT05755360
• A Research Study Looking at How a Single Dose of the Medicine NNC0194-0499 Behaves in Chinese MenCompletedNCT05742919Phase 1
• Attitudes and Unmet Needs Among Type 2 Diabetes PatientsCompletedNCT05737810
• Persons With Obesity (PwO) Exploratory ResearchCompletedNCT05736120
• A Research Study Looking Into Blood and Urine Levels of the Medicine NNC0194-0499 in the Body and How Well it is Tolerated in Participants With Reduced Kidney Function and Normal Kidney FunctionCompletedNCT05727644Phase 1
• A Research Study on How Well Semaglutide Helps Children and Teenagers With Excess Body Weight Lose WeightActive, not recruitingNCT05726227Phase 3
• Study of the Effect of Etavopivat on Cerebral Hemodynamic Response in Children With Sickle Cell DiseaseCompletedNCT05725902Phase 2
• A Research Study Looking Into Blood Levels of Three Different Formulations of the Study Medicine ZiltivekimabCompletedNCT05721989Phase 1
• O-SEMA-Fast: A Research Study to Understand How Oral Semaglutide Works in People With Type 2 Diabetes Who Plan to Fast During Ramadan in the United Arab Emirates, Saudi Arabia, and KuwaitCompletedNCT05716724
• Awareness, Care & Treatment In Obesity ManagementCompletedNCT05690789
• A Research Trial Looking at the Comparability of 2 Different Concentrations of Semaglutide for the 0.5 Milligram (mg) DoseCompletedNCT05689099Phase 1
• A Research Study Looking at Long-term Treatment With Mim8 in People With Haemophilia AActive, not recruitingNCT05685238Phase 3
• A Study to Compare the Blood Levels of Mim8 in Healthy Men When Administered With the DV3407-C1 Pen Injector or a Syringe and CartridgeCompletedNCT05681845Phase 1
• REDEFINE 3: A Research Study to See the Effects of CagriSema in People Living With Diseases in the Heart and Blood VesselsActive, not recruitingNCT05669755Phase 3
• Obesity and Cardiovascular Diseases, Cross-sectional Study in Saudi ArabiaCompletedNCT05642533
• A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Heart Failure and InflammationTerminatedNCT05636176Phase 3
• A Study to Look at Safety and Tolerability of NNC0582-0001, How it is Transported Throughout the Body and How it Works in Healthy AdultsCompletedNCT05624580Phase 1
• An Observational Research Study of the Health of Joints in People With Haemophilia Taking the Medicine EsperoctCompletedNCT05621746
• First Human Dose Trial for a New Medication to Potentially Treat Liver DiseasesCompletedNCT05599945Phase 1
• A Research Study to See How Well CagriSema Helps People With Excess Body Weight Lose WeightActive, not recruitingNCT05567796Phase 3
• A Research Study Looking at How a Single Dose of the Medicine Cagrilintide Works in Participants With Reduced Liver Function and in Healthy Participants With Normal Liver Function and How Cagrilintide is Absorbed and Used by the BodyCompletedNCT05564104Phase 1
• A Research Study, Looking at the Characterization of Treatment Intensified (Add on to Metformin) Real-world Adult Population With Type 2 Diabetes Mellitus in India, Pakistan and Thailand.CompletedNCT05542420
• A Research Study of a New Medicine NNC0113-6856 in Healthy MalesCompletedNCT05521256Phase 1
• Phase 2 Study of INV-202 in Patients With Diabetic Kidney DiseaseCompletedNCT05514548Phase 2
• A Research Study to Understand How Oral Semaglutide Works in People With Type 2 Diabetes in IndiaCompletedNCT05502562
• A Research Study of How the Medicine NNC0480-0389 Taken With Semaglutide Works in the Body of Healthy Chinese MenCompletedNCT05498610Phase 1
• A Research Study Looking at Blood Sugar Control in People With Type 2 Diabetes Previously Treated With Premix Insulin and Initiating Treatment With Insulin Degludec/Liraglutide (IDegLira) in Local Clinical Practice in CroatiaWithdrawnNCT05479591
• A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Germany, as Part of Local Clinical PracticeWithdrawnNCT05473286
• A Study in North Macedonia Investigating Retrospective Data of Glucagon-like Peptide-1 (GLP-1) Participants With Type 2 Diabetes (T2D) in Real World Environment (RWE) Setting (MIRAGE)CompletedNCT05468632
• Research Study to Compare Semaglutide Tablets With Empagliflozin Tablets Taken Once Daily in People With Type 2 Diabetes and ObesityWithdrawnNCT05444153Phase 3
• A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Israel, as Part of Local Clinical PracticeCompletedNCT05443568
• A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Spain, as Part of Local Clinical PracticeCompletedNCT05443334
• A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Finland, as Part of Local Clinical PracticeCompletedNCT05443191
• A Research Study to Look at How a New Medicine Called NNC6019-0001 Works and How Safe it is for People Who Have Heart Disease Due to Transthyretin (TTR) AmyloidosisCompletedNCT05442047Phase 2
• INSPIRE Turkey :A Research Study Looking at the Clinical Parameters Associated With Use and Discontinuation of Saxenda® in Local Clinical Practice in Turkey by Analysing Past Patient Medical RecordsWithdrawnNCT05438186
• A Research Study to Look at How Insulin Icodec and Semaglutide Work in the Body of People From China With Type 2 Diabetes When Given Alone or TogetherCompletedNCT05435677Phase 1
• A Research Study Investigating How Semaglutide and Dapagliflozin Act in Your Body When Dosed in One TabletCompletedNCT05429593Phase 1
• Awareness, Care & Treatment In Obesity Management - An Observation in Mainland ChinaCompletedNCT05428501
• Research Study Investigating How Well NDec Works in People With Sickle Cell DiseaseCompletedNCT05405114Phase 2
• A Research Study to See How Well CagriSema Helps People With Type 2 Diabetes and Excess Body Weight Lose WeightCompletedNCT05394519Phase 3
• A Research Study of How the Medicine Ziltivekimab Works in the Body of Chinese Men and Women With Kidney Disease and InflammationCompletedNCT05379829Phase 1
• A Research Study on How NNC0487-0111 Works in People With Overweight or ObesityCompletedNCT05369390Phase 1
• A Research Study of a New Medicine NNC0519-0130 in Healthy People, People With High Body Weight and People With Type 2 Diabetes.CompletedNCT05363774Phase 1
• A Research Study Looking at New Protein-based Tablets in Healthy Men - Oral Formulation IICompletedNCT05333107Phase 1
• A Research Study to Compare Somapacitan Once a Week With Norditropin® Once a Day in Children Who Need Help to GrowActive, not recruitingNCT05330325Phase 3
• Glycaemic Control and Other Clinical Parameters in Adult Type 2 Diabetes Patients on Basal Insulin Initiating Treatment With IDegLira in Routine Clinical Practice in ColombiaCompletedNCT05324462
• An International Chart Review and Survey for the Prevalence and Clinical Management of Atherosclerotic Cardiovascular Diseases in Patients With Type 2 Diabetes Across Countries in the Middle East and AfricaCompletedNCT05317845
• A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Mexico, as Part of Local Clinical PracticeCompletedNCT05316662

← Novo Nordisk A/S overview and focus areas